Cargando…

Novel PET/SPECT Probes for Imaging of Tau in Alzheimer's Disease

As the world's population ages, the number of patients with Alzheimer's disease (AD) is predicted to increase rapidly. The presence of neurofibrillary tangles (NFTs), composed of hyperphosphorylated tau protein, is one of the neuropathological hallmarks of AD brain. Since the presence of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Hiroyuki, Ono, Masahiro, Saji, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386695/ https://www.ncbi.nlm.nih.gov/pubmed/25879047 http://dx.doi.org/10.1155/2015/124192

Ejemplares similares

Highly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer’s Disease
por: Ono, Masahiro, et al.
Publicado: (2016)

SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques
por: Ono, Masahiro, et al.
Publicado: (2011)

Development of Novel (123)I-Labeled Pyridyl Benzofuran Derivatives for SPECT Imaging of β-Amyloid Plaques in Alzheimer’s Disease
por: Ono, Masahiro, et al.
Publicado: (2013)

Feasibility of Amylin Imaging in Pancreatic Islets with β-Amyloid Imaging Probes
por: Yoshimura, Masashi, et al.
Publicado: (2014)

Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018)

Novel Bivalent (99m)Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
por: Iikuni, Shimpei, et al.
Publicado: (2016)

Development of PET and SPECT Probes for Glutamate Receptors
por: Fuchigami, Takeshi, et al.
Publicado: (2015)

Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases
por: Shimizu, Yoichi, et al.
Publicado: (2019)

SPECT and PET Imaging of Meningiomas
por: Valotassiou, Varvara, et al.
Publicado: (2012)

PET-MR and SPECT-MR multimodality probes: Development and challenges
por: Yang, Chang-Tong, et al.
Publicado: (2018)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
por: Shao, Tuo, et al.
Publicado: (2019)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
por: Declercq, Lieven D., et al.
Publicado: (2016)

Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Imaging the DNA damage response with PET and SPECT
por: Knight, James C., et al.
Publicado: (2017)

PET and SPECT Imaging of ALS: An Educational Review
por: Jamali, Ayaan M., et al.
Publicado: (2023)

In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe
por: Shimizu, Yoichi, et al.
Publicado: (2014)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
por: Jie, Caitlin V. M. L., et al.
Publicado: (2021)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Molecular imaging of plaques in coronary arteries with PET and SPECT
por: Sun, Zhong-Hua, et al.
Publicado: (2014)

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
por: Jeon, Seun, et al.
Publicado: (2019)

Characteristics of Tau and Its Ligands in PET Imaging
por: Harada, Ryuichi, et al.
Publicado: (2016)

Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
por: Rempel, Brian P., et al.
Publicado: (2017)

Development of a Radioiodinated Triazolopyrimidine Probe for Nuclear Medical Imaging of Fatty Acid Binding Protein 4
por: Nishigori, Kantaro, et al.
Publicado: (2014)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Reporter Genes for Brain Imaging Using MRI, SPECT and PET
por: Gao, Tianxin, et al.
Publicado: (2022)

Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease
por: Weih, Markus, et al.
Publicado: (2010)

Investigation of a MMP-2 Activity-Dependent Anchoring Probe for Nuclear Imaging of Cancer
por: Temma, Takashi, et al.
Publicado: (2014)

Towards authentically labelled bi-modal PET (SPECT)/MR-probes
por: Coenen, Heinrich H, et al.
Publicado: (2014)

International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022)

SPECT vs. PET in cardiac innervation imaging: clash of the titans
por: Werner, Rudolf A., et al.
Publicado: (2018)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer’s Disease With Amyloid-PET
por: Takahashi, Miwako, et al.
Publicado: (2019)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
por: Rinne, Sara S., et al.
Publicado: (2021)

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET
por: Mohammadi, Zohreh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cgbrksededelkbg2csu3ttncsi